Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine as an adjuvant to ropivacaine for thoracic paravertebral block in thoracoscopic surgery
ChiCTR2100042597Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and ropivacaine in postoperative pain (2 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoint: Morphine consumption 24 hours after surgery. Started Mar 2021; status: recruiting.
02
Drugs
esketamineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100042597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042597.